Guidelines for Complicated Urinary Tract Infections in Children: A Review by the European Society for Pediatric Infectious Diseases

ESPID · 2025 · Europe

Source and licence

Authors
Penelope A Bryant, Maria Bitsori, Kalliopi Vardaki et al.
Title
Guidelines for Complicated Urinary Tract Infections in Children: A Review by the European Society for Pediatric Infectious Diseases
Journal
The Pediatric Infectious Disease Journal, 2025
Licence
CC BY 4.0
Changes
Verbatim excerpts; formatting adapted

Full text retrieved 2026-10-27 from Europe PMC · PMC12058373

Licence statement of the original publication

This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

This page reproduces excerpts of the original publication; the original is authoritative. It has not been reviewed by a physician, does not state a recommendation of Medelix and does not replace medical advice. The guideline may have been updated since.

Open the original publication →Full text on Europe PMC

Recommendations

We found no explicitly labelled recommendations in this publication; its recommendations are in the running text of the original.

Abstract

Background: Complicated urinary tract infections (cUTI) present a challenge to the clinician because of the variety in clinical syndromes included and consequent difficulties in synthesizing evidence. A harmonized definition of cUTI does not exist. In national guidelines, management recommendations for cUTI are often neglected. We aimed to define the four most important controversies and formulate management recommendations for cUTI in children and adolescents.

Methods: The European Society of Pediatric Infectious Diseases Guideline Committee convened a working group of experts from microbiology, pediatric nephrology and infectious diseases with expertise in managing children with UTI. A comprehensive literature review was done using PubMed, Embase and the Cochrane library to find studies in children under 18 years published until December 2024. Four controversies were defined from experience and available evidence. Children with cUTI were categorized into 5 subgroups: anatomical/functional urological abnormalities, multiple UTI recurrences, severe clinical presentation, nonurological underlying conditions and neonates. Respective management guidelines were formulated through the evidence and by consensus of working group members. Recommendations were made using GRADE criteria.

Results: The term cUTI is generally used to define children with UTI with an increased likelihood of failing conventional management. The included 5 subgroups are the most likely to need additional investigations at diagnosis and during the course of infection, initial intravenous antibiotics, longer treatment duration, antibiotic prophylaxis, follow-up imaging and surgical referral. These are detailed for each subgroup.

Conclusions: These comprehensive guidelines offer evidence-graded recommendations specifically for pediatric cUTI, addressing gaps that exist in current guidelines.

Contents of the original publication

The section headings of the original.

  • INTRODUCTION
  • METHODS
  • RESULTS
  • What Is the Definition of cUTI?
  • Which Investigations Are Needed at Diagnosis and During Complicated UTI?
  • Urine Dipstick Analysis
  • Urine Microscopy
  • Urine Culture
  • How Should Children With cUTI be Treated?
  • Initial Antibiotic Route
  • Empiric Antibiotic Choice
  • Antibiotic Duration and Timing of IV to Oral Switch
  • Supportive Management
  • How Should We Follow Up Children With cUTI?
  • Antimicrobial prophylaxis
  • Effectiveness for cUTI Subgroups
  • Antibiotic Prophylaxis Choice, Duration and Resistance
  • Further Imaging
  • Ultrasound Scan
  • Micturating Cystourethrography
  • DMSA Scan
  • Magnetic Resonance Urography
  • Referral
  • DISCUSSION AND CONCLUSIONS
  • Contributor Information

A question about this guideline?

Medelix answers clinical questions from guidelines and studies – every statement with its source.

Are you the rights holder and object to this reproduction? Write to contact@medelix.ai and we will take the page down promptly. Imprint